Research Article
Emerging Challenges in Staphylococcus aureus Bloodstream Infections: Insights from Coagulase Typing, Toxin Genes, and Antibiotic Resistance Patterns
Table 2
Antibiotic resistance pattern of 120 S. aureus isolates collected from blood samples.
| | Antibiotics | MRSA, n (%) | MSSA, n (%) | Total resistance, n (%) |
| | Ampicillin | 70 (63.1) | 41 (36.9) | 111 (92.5) | | Amikacin | 45 (54.9) | 37 (45.1) | 82 (68.3) | | Rifampin | 27 (69.2) | 12 (30.8) | 39 (32.5) | | Trimethoprim-sulfamethoxazole | 10 (62.5) | 6 (37.5) | 16 (13.3) | | Erythromycin | 47 (63.5) | 27 (36.5) | 74 (61.7) | | Tetracycline | 35 (62.5) | 21 (37.5) | 56 (46.7) | | Gentamycin | 55 (66.3) | 28 (33.7) | 83 (69.2) | | Kanamycin | 32 (68.1) | 15 (31.9) | 47 (39.2) | | Clindamycin | 42 (76.4) | 13 (23.6) | 55 (45.8) | | Cefazoline | 19 (79.2) | 5 (20.8) | 24 (20) | | Ciprofloxacin | 39 () | 12 (12) | 51 (42.5) | | Chloramphenicol | 19 (79.2) | 5 (20.8) | 24 (20) |
|
|
